AzTrials
AzTrials

HomelessnessNCT07209072

Emergency Department Linkage to Care for Patients Experiencing Homelessness

A study testing Street medicine follow up in people with Homelessness, run by Denver Health and Hospital Authority at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

In an effort to improve access to primary care at time of discharge, patients who are homeless will be given either enhanced follow up through a street medicine team or routine follow up in clinic. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Homelessness
What is being tested?
Street medicine follow up
Could I receive a placebo?
No, everyone receives an active treatment
How many people
390 participants
Where
1 siteUnited States
Study dates
5 Dec 2025to Dec 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult (≥18 years of age) DHMC ED patient,
  • currently unsheltered, defined as living on the streets, in a vehicle, or in another place not fit for human habitation,
  • anticipating ED discharge, with
  • a diagnosis listed below that requires short-term follow up:
  • COPD or asthma exacerbation
  • Bacterial or viral pneumonia
Show all 18Show fewer
  • CHF with volume overload
  • SSTI
  • Dehydration requiring IV fluids
  • Hyperglycemia secondary to DM
  • Frostbite
  • First- and second-degree burns
  • Bacterial ENT infections
  • Diabetic foot infection
  • Traumatic head injury
  • Pregnancy
  • Opioid overdose
  • a stable location (i.e., an intersection, landmark, or encampment where they can be located by the street medicine team) within Denver County for at least 2 weeks.

Who cannot join

  • have altered mentation (e.g., intoxication, or secondary to medical, psychiatric, or behavioral conditions) that are unable to communicate their location, contact information, or agree to follow up.
  • are prisoners,
  • previously enrolled.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kathleen M Joseph, MD MPH contact

13175194468

kathleen.joseph@dhha.org

Carolynn Lyle, PAC MPH contact

carol.lyle@dhha.org

United States1 site, 1 recruiting
  • Denver Health Medical Center

    Denver, Colorado, 80204

    Kathleen Joseph, MD MPH, 3036020396, kathleen.joseph@dhha.org

    Carolynn Lyle, PA-C MPH, carol.lyle@dhha.org

    Recruiting

Other trials in United States

About this study

In an effort to improve access to primary care at time of discharge, patients who are homeless will be given either enhanced follow up through a street medicine team or routine follow up in clinic.

Read the detailed description

Patients who experience homelessness frequently utilize the ED, but lack follow up primary care. In an effort to augment access to post-ED primary care, the investigators propose a quasi-experimental equivalent time sample study in which patients fitting certain diagnostic and inclusion criteria are allocated to either a) a referral to the Comprehensive Care Clinic at Denver Health, or b) a referral to Colorado Coalition for the Homeless (CCH) Stout Street medicine clinic. The street medicine clinic aims to lower barriers to access by locating patients on the street and providing primary care rather than asking patients to present to clinic. All patients will still receive the hospital appointment line number at time of discharge. 1 month and 3 months after index visit, the investigators will examine follow up rates at both clinics as well as secondary outcomes including ED visits, hospitalizations, and mortality through chart review of Denver Health and CCH electronic health records and CORHIO.

Conditions
Homelessness
Being tested
Street medicine follow up
Keywords
primary care, emergency department, homelessness
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Street medicine follow upBehavioural

    This intervention will use electronic health record builds to automatically send a referral to a street medicine clinic, who will attempt to contact the patient within 2 weeks.

Study groups in NCT07209072
Study groupRoleWhat they receive
Standard of CareNo interventionPatients will receive a referral to a rapid follow up clinic at time of discharge
Street medicineExperimentalPatients will receive a referral to street medicine at time of discharge
Receives: Behavioral: Street medicine follow up

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ED visits

    Repeat visits to the ED

    Measured: 1 and 3 months

Secondary outcomes (2)
  1. Inpatient hospitalizations

    Inpatient hospitalizations at this same hospital

    Measured: 1 and 3 months

  2. Mortality

    Death

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2025
  2. Study start5 Dec 2025
  3. Primary completionJun 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
390 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07209072
Sponsor's protocol ID
COMIRB 24-1764
Other IDs
F32HS030344
Status last verified
Jan 2026
First submitted
30 Sep 2025
Last updated
28 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: At this time there is no plan to share IPD. Sharing of data will be considered on a case by case basis and only de-identified data will be shared.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in